Bornstein Amphitheater | 1pm – 2pm
We have come a long way from the $2.7 billion Human Genome Project to an era where the $1000 genome might actually become a reality. Doctors and patients alike are unraveling the genome as a means to understanding disease at the level of the individual. This concept of personalized medicine or precision medicine holds immense promise for curing conditions from blood clots to many types of cancer. In this session, Drs. Morton and MacRae and their respective patients talk about how your genome might hold the key to good health from conception all the way to your golden years.
Heidi Rehm, PhD
Associate Professor of Pathology, Brigham & Women’s Hospital and Harvard Medical School; Chief Laboratory Director, Laboratory for Molecular Medicine, Partners Healthcare Center for Personalized Genetic Medicine
Heidi Rehm was recruited in 2001 to build the Laboratory for Molecular Medicine at PCPGM and now serves as its Director. She is a board-certified clinical molecular geneticist and Associate Professor of Pathology. In addition to running the LMM and the HMS clinical molecular genetics training program, she also conducts research in hearing loss, cardiomyopathy and the use of IT in enabling personalized medicine. Most recently she received a collaborative grant to launch the NIH-funded Clinical Genome Resource Program focused on developing resources to support genomic medicine through data sharing and knowledge curation.
Moderated by Carey Goldberg, CommonHealth Blog
Carey Goldberg is the co-host of WBUR’s CommonHealth blog and reports frequently about health on the air. She has been the Boston bureau chief of The New York Times, a staff Moscow correspondent for The Los Angeles Times, and a health/science reporter for The Boston Globe. She was a Knight Science Journalism fellow at MIT; graduated summa cum laude from Yale; and did graduate work at Harvard. She is co-author of the triple memoir “Three Wishes: A True Story Of Good Friends, Crushing Heartbreak and Astonishing Luck On Our Way To Love and Motherhood.”
Calum MacRae & patient
Cynthia Morton, PhD & patient
Cynthia Casson Morton is the William Lambert Richardson Professor of Obstetrics, Gynecology and Reproductive Biology and Professor of Pathology at Harvard Medical School, Director of Cytogenetics and Past Director of the Biomedical Research Institute at Brigham and Women’s Hospital. Dr. Morton is certified by the American Board of Medical Genetics in Ph.D. Medical Genetics, Clinical Cytogenetics and Clinical Molecular Genetics. Her research interests are in molecular cytogenetics, hereditary deafness, genetics of uterine leiomyomata and human developmental disorders. She has published over 260 original articles. Dr. Morton is a member of the Board of Directors of the American Society of Human Genetics and most recently completed a six year tenure as Editor of The American Journal of Human Genetics. Dr. Morton is currently a member of the Counsel of Scientific Trustees of the Hearing Health Foundation, and Chair of the Veteran’s Administration Genomic Medicine Program Advisory Committee. Dr. Morton is President-elect of the American Society of Human Genetics and will serve as President in 2014.
Cynthia Morton, PhD
Heidi Rehm, PhD